Ganaxolone is a DEA Schedule V controlled substance. Substances in the DEA Schedule V have a low potential for abuse relative to substances listed in Schedule IV and consist mainly of preparations containing limited quantities of certain narcotics. It is a Depressants substance. It is grouped under the following drug class(es): Schedule V controlled substances. Its therapeutic use is listed as anti-epileptic drugs, anticonvulsants and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ztalmy and Ganaxolonum. It is listed as a controlled drug substance (Schedule V). Its PubChem CID is 6918305.
Ganaxolone
| CAS No | 38398-32-2 |
|---|---|
| Molecular Formula | C22H36O2 |
| Molecular Weight | 332.5 g/mol |
| Synonyms | 1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ganaxolone is a DEA Schedule V controlled substance. Substances in the DEA Schedule V have a low potential for abuse relative to substances listed in Schedule IV and consist mainly of preparations containing limited quantities of certain narcotics.
The listed CAS number is 38398-32-2.
The listed molecular formula is C22H36O2.
The listed molecular weight is 332.5 g/mol.
1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone.
The source lists Ztalmy and Ganaxolonum.